• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多能干细胞基因编辑的进展与展望

Progress and Prospects of Gene Editing in Pluripotent Stem Cells.

作者信息

Zhang Zhenwu, Bao Xinyu, Lin Chao-Po

机构信息

School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.

出版信息

Biomedicines. 2023 Aug 1;11(8):2168. doi: 10.3390/biomedicines11082168.

DOI:10.3390/biomedicines11082168
PMID:37626665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10452926/
Abstract

Applying programmable nucleases in gene editing has greatly shaped current research in basic biology and clinical translation. Gene editing in human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), is highly relevant to clinical cell therapy and thus should be examined with particular caution. First, since all mutations in PSCs will be carried to all their progenies, off-target edits of editors will be amplified. Second, due to the hypersensitivity of PSCs to DNA damage, double-strand breaks (DSBs) made by gene editing could lead to low editing efficiency and the enrichment of cell populations with defective genomic safeguards. In this regard, DSB-independent gene editing tools, such as base editors and prime editors, are favored due to their nature to avoid these consequences. With more understanding of the microbial world, new systems, such as Cas-related nucleases, transposons, and recombinases, are also expanding the toolbox for gene editing. In this review, we discuss current applications of programmable nucleases in PSCs for gene editing, the efforts researchers have made to optimize these systems, as well as new tools that can be potentially employed for differentiation modeling and therapeutic applications.

摘要

在基因编辑中应用可编程核酸酶极大地塑造了当前基础生物学研究和临床转化的格局。人类多能干细胞(PSCs)中的基因编辑,包括胚胎干细胞(ESCs)和诱导多能干细胞(iPSCs),与临床细胞治疗高度相关,因此应格外谨慎地进行研究。首先,由于PSCs中的所有突变都会传递给其所有后代,编辑工具的脱靶编辑会被放大。其次,由于PSCs对DNA损伤高度敏感,基因编辑产生的双链断裂(DSBs)可能导致编辑效率低下,并使具有缺陷基因组保护机制的细胞群体富集。在这方面,不依赖DSB的基因编辑工具,如碱基编辑器和引导编辑器,因其能够避免这些后果的特性而受到青睐。随着对微生物世界的更多了解,新的系统,如与Cas相关的核酸酶、转座子和重组酶,也在不断扩展基因编辑的工具库。在这篇综述中,我们讨论了可编程核酸酶在PSCs基因编辑中的当前应用、研究人员为优化这些系统所做的努力,以及可潜在用于分化建模和治疗应用的新工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10452926/60afe6014214/biomedicines-11-02168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10452926/6c3f53051454/biomedicines-11-02168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10452926/60afe6014214/biomedicines-11-02168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10452926/6c3f53051454/biomedicines-11-02168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10452926/60afe6014214/biomedicines-11-02168-g002.jpg

相似文献

1
Progress and Prospects of Gene Editing in Pluripotent Stem Cells.多能干细胞基因编辑的进展与展望
Biomedicines. 2023 Aug 1;11(8):2168. doi: 10.3390/biomedicines11082168.
2
The "new favorite" of gene editing technology-single base editors.基因编辑技术的“新宠”——单碱基编辑器。
Yi Chuan. 2017 Dec 20;39(12):1115-1121. doi: 10.16288/j.yczz.17-389.
3
Genome Engineering Human ESCs or iPSCs with Cytosine and Adenine Base Editors.使用胞嘧啶碱基编辑器和腺嘌呤碱基编辑器对人类胚胎干细胞或诱导多能干细胞进行基因组工程改造。
Methods Mol Biol. 2022;2520:321-333. doi: 10.1007/7651_2022_461.
4
Precise homology-directed installation of large genomic edits in human cells with cleaving and nicking high-specificity Cas9 variants.利用切割和缺口高特异性 Cas9 变体在人细胞中精确同源定向安装大型基因组编辑。
Nucleic Acids Res. 2023 Apr 24;51(7):3465-3484. doi: 10.1093/nar/gkad165.
5
In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.PCSK9(前蛋白转化酶枯草杆菌蛋白酶/克新9型)的体内碱基编辑作为基因组编辑的一种治疗替代方法。
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1741-1747. doi: 10.1161/ATVBAHA.117.309881. Epub 2017 Jul 27.
6
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.利用 CRISPR-Cas 核酸酶、碱基编辑器、转座酶和 Prime 编辑器进行基因组编辑。
Nat Biotechnol. 2020 Jul;38(7):824-844. doi: 10.1038/s41587-020-0561-9. Epub 2020 Jun 22.
7
High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells.尿嘧啶DNA糖基化酶的高表达决定了人类多能干细胞中C到T的替换。
Mol Ther Nucleic Acids. 2021 Nov 29;27:175-183. doi: 10.1016/j.omtn.2021.11.023. eCollection 2022 Mar 8.
8
Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.高效基因组编辑工具;ZFN、TALEN 和 CRISPR。
Methods Mol Biol. 2022;2495:29-46. doi: 10.1007/978-1-0716-2301-5_2.
9
Genome editing in pluripotent stem cells: research and therapeutic applications.多能干细胞中的基因组编辑:研究与治疗应用
Biochem Biophys Res Commun. 2016 May 6;473(3):665-74. doi: 10.1016/j.bbrc.2016.02.113. Epub 2016 Feb 27.
10
CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.CRISPR-Cas9:一种用于诱导多能干细胞基因编辑的有前景的工具。
Korean J Intern Med. 2017 Jan;32(1):42-61. doi: 10.3904/kjim.2016.198. Epub 2017 Jan 1.

引用本文的文献

1
Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review.探索干细胞疗法在神经退行性疾病和脊髓损伤中的新兴作用:一项叙述性综述
Cureus. 2025 Aug 8;17(8):e89629. doi: 10.7759/cureus.89629. eCollection 2025 Aug.
2
Pluripotent Stem Cells: Recent Advances and Emerging Trends.多能干细胞:最新进展与新兴趋势
Biomedicines. 2025 Mar 21;13(4):765. doi: 10.3390/biomedicines13040765.
3
Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling.环状CRISPR编辑人类多能干细胞用于疾病建模。

本文引用的文献

1
Programmable RNA-guided DNA endonucleases are widespread in eukaryotes and their viruses.可编程 RNA 引导的 DNA 内切酶在真核生物及其病毒中广泛存在。
Sci Adv. 2023 Sep 29;9(39):eadk0171. doi: 10.1126/sciadv.adk0171. Epub 2023 Sep 27.
2
Fanzor is a eukaryotic programmable RNA-guided endonuclease.范宰是一种真核可程控 RNA 引导的内切核酸酶。
Nature. 2023 Aug;620(7974):660-668. doi: 10.1038/s41586-023-06356-2. Epub 2023 Jun 28.
3
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos.
Stem Cell Rev Rep. 2025 Apr 7. doi: 10.1007/s12015-025-10871-2.
4
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases.基因编辑与纳米技术在基于干细胞的人类疾病治疗中的应用。
Stem Cell Rev Rep. 2025 Feb 27. doi: 10.1007/s12015-025-10857-0.
5
Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells.干细胞疗法治疗肌萎缩侧索硬化症:间充质干细胞、神经干细胞和诱导多能干细胞疗效比较
Biomedicines. 2024 Dec 27;13(1):35. doi: 10.3390/biomedicines13010035.
6
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing.通过CRISPR碱基编辑引入的回复突变实现F508del-CFTR的功能挽救。
Mol Ther. 2025 Mar 5;33(3):970-985. doi: 10.1016/j.ymthe.2025.01.011. Epub 2025 Jan 10.
7
Synergy between pluripotent stem cell-derived macrophages and self-renewing macrophages: Envisioning a promising avenue for the modelling and cell therapy of infectious diseases.多能干细胞衍生巨噬细胞与自我更新巨噬细胞之间的协同作用:为传染病建模和细胞治疗设想一条充满希望的途径。
Cell Prolif. 2025 Feb;58(2):e13770. doi: 10.1111/cpr.13770. Epub 2024 Nov 13.
8
Global Knowledge Map and Emerging Research Trends in Induced Pluripotent Stem Cells and Hereditary Diseases: A CiteSpace-based Visualization and Analysis.诱导多能干细胞与遗传性疾病的全球知识图谱及新兴研究趋势:基于CiteSpace的可视化分析
Stem Cell Rev Rep. 2025 Jan;21(1):126-146. doi: 10.1007/s12015-024-10799-z. Epub 2024 Oct 8.
腺嘌呤颠换编辑器可在哺乳动物细胞和胚胎中实现精确、高效的 A•T 到 C•G 碱基编辑。
Nat Biotechnol. 2024 Apr;42(4):638-650. doi: 10.1038/s41587-023-01821-9. Epub 2023 Jun 15.
4
iPSC-based research in ALS precision medicine.基于 iPSC 的肌萎缩侧索硬化症精准医学研究。
Cell Stem Cell. 2023 Jun 1;30(6):748-749. doi: 10.1016/j.stem.2023.05.008.
5
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.靶向DNA去甲基化:载体、效应物与展望
Biomedicines. 2023 Apr 30;11(5):1334. doi: 10.3390/biomedicines11051334.
6
Development of miniature base editors using engineered IscB nickase.利用工程化的 IscB 核酸内切酶开发微型碱基编辑器。
Nat Methods. 2023 Jul;20(7):1029-1036. doi: 10.1038/s41592-023-01898-9. Epub 2023 May 25.
7
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.肽介导的 CRISPR 酶递送来高效编辑原代人淋巴细胞。
Nat Biomed Eng. 2023 May;7(5):647-660. doi: 10.1038/s41551-023-01032-2. Epub 2023 Apr 25.
8
A highly efficient transgene knock-in technology in clinically relevant cell types.一种在临床相关细胞类型中高效的转基因敲入技术。
Nat Biotechnol. 2024 Mar;42(3):458-469. doi: 10.1038/s41587-023-01779-8. Epub 2023 May 1.
9
Prediction of efficiencies for diverse prime editing systems in multiple cell types.预测多种细胞类型中不同的 Prime Editing 系统的效率。
Cell. 2023 May 11;186(10):2256-2272.e23. doi: 10.1016/j.cell.2023.03.034. Epub 2023 Apr 28.
10
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing.使用肽辅助基因组编辑技术高效工程化人类和小鼠原代细胞。
Nat Biotechnol. 2024 Feb;42(2):305-315. doi: 10.1038/s41587-023-01756-1. Epub 2023 Apr 24.